WO2006008757A3 - Stabilized pharmaceutical compositions of pravastatin - Google Patents
Stabilized pharmaceutical compositions of pravastatin Download PDFInfo
- Publication number
- WO2006008757A3 WO2006008757A3 PCT/IN2005/000191 IN2005000191W WO2006008757A3 WO 2006008757 A3 WO2006008757 A3 WO 2006008757A3 IN 2005000191 W IN2005000191 W IN 2005000191W WO 2006008757 A3 WO2006008757 A3 WO 2006008757A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pravastatin
- pharmaceutical compositions
- stabilized pharmaceutical
- stabilized
- pharmaceutically acceptable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN518/MUM/2004 | 2004-05-05 | ||
IN518MU2004 | 2004-05-05 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2006008757A2 WO2006008757A2 (en) | 2006-01-26 |
WO2006008757A3 true WO2006008757A3 (en) | 2006-04-27 |
Family
ID=35550643
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IN2005/000191 WO2006008757A2 (en) | 2004-05-05 | 2005-05-05 | Stabilized pharmaceutical compositions of pravastatin |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2006008757A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3060390B1 (en) * | 2016-12-19 | 2020-09-25 | Bh Pharma | FORMULATION CONSISTING OF PRAVASTATIN AND ACETYLSALYCILIC ACID |
CN110840866A (en) * | 2018-08-20 | 2020-02-28 | 成都新睿泰康科技有限公司 | Asarin pharmaceutical composition and application thereof in preventing and treating neurodegenerative diseases |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5030447A (en) * | 1988-03-31 | 1991-07-09 | E. R. Squibb & Sons, Inc. | Pharmaceutical compositions having good stability |
WO2000035425A1 (en) * | 1998-12-16 | 2000-06-22 | Lek Pharmaceutical And Chemical Company D.D. | STABLE PHARMACEUTICAL FORMULATION COMPRISING A HMG-CoA REDUCTASE INHIBITOR |
WO2002076376A2 (en) * | 2001-03-27 | 2002-10-03 | Ranbaxy Laboratories Limited | A stable pharmaceutical composition of pravastatin |
WO2003000239A1 (en) * | 2001-06-21 | 2003-01-03 | Andrx Pharmaceuticals, Inc. | Stable pharmaceutical compositions containing pravastatin |
WO2005013940A1 (en) * | 2003-08-06 | 2005-02-17 | Galephar M/F | Stable controlled release pharmaceutical compositions containing fenofibrate and pravastatin |
-
2005
- 2005-05-05 WO PCT/IN2005/000191 patent/WO2006008757A2/en active Application Filing
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5030447A (en) * | 1988-03-31 | 1991-07-09 | E. R. Squibb & Sons, Inc. | Pharmaceutical compositions having good stability |
WO2000035425A1 (en) * | 1998-12-16 | 2000-06-22 | Lek Pharmaceutical And Chemical Company D.D. | STABLE PHARMACEUTICAL FORMULATION COMPRISING A HMG-CoA REDUCTASE INHIBITOR |
WO2002076376A2 (en) * | 2001-03-27 | 2002-10-03 | Ranbaxy Laboratories Limited | A stable pharmaceutical composition of pravastatin |
WO2003000239A1 (en) * | 2001-06-21 | 2003-01-03 | Andrx Pharmaceuticals, Inc. | Stable pharmaceutical compositions containing pravastatin |
WO2003000177A2 (en) * | 2001-06-21 | 2003-01-03 | Andrx Pharmaceuticals, Inc. | Stable controlled release pharmaceutical compositions containing pravastatin |
WO2005013940A1 (en) * | 2003-08-06 | 2005-02-17 | Galephar M/F | Stable controlled release pharmaceutical compositions containing fenofibrate and pravastatin |
Also Published As
Publication number | Publication date |
---|---|
WO2006008757A2 (en) | 2006-01-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DZ3312A1 (en) | Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and preparation thereof | |
WO2007041156A3 (en) | Antibiotic formulations, unit doses, kits, and methods | |
NZ597260A (en) | Formulations for parenteral delivery of compounds and uses thereof comprising methylnaltrexone | |
WO2006010560A8 (en) | Physiologically active composition | |
IL165383A (en) | Pharmaceutical compositions comprising a salt or co-crystal of celecoxib, surfactant and a cellulose derivative | |
WO2006096439A3 (en) | Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases | |
WO2006118948A3 (en) | Therapeutic compositions | |
WO2008009379A3 (en) | Active ingredient combinations having insecticide and acaricide properties | |
MX2007013623A (en) | External preparation for skin. | |
WO2006116733A3 (en) | Protein kinase inhibitors | |
WO2008062476A3 (en) | Pharmaceutical composition comprising rosuvastatin or pharmaceutically accepatble salts thereof | |
EP1340755A4 (en) | Anti-helicobacterial agents | |
WO2004017998A3 (en) | Topical emulsion- gel composition comprising diclofenac sodium | |
WO2008026048A3 (en) | Stable injectable pharmaceutical compositions of docetaxel | |
EP2153834A3 (en) | Extended release pharmaceutical compositions comprising quetiapine salts | |
UA96759C2 (en) | 2-ARYLINDOLE DERIVATIVES AS mPGES-I INHIBITORS | |
MXPA03011480A (en) | Aqueous cilostazol preparation for injection. | |
EP1935417A4 (en) | Composition for use in prevention of hypoglycemic condition | |
WO2007058568A3 (en) | Salts of 9-oxoacridine-10-acetic acid with 1-alkylamino-1-desoxy-polyols | |
WO2006110810A3 (en) | Polymorphs of 3-o-(3',3'-dimethylsuccinyl) betulinic acid di-n-methyl-d-glucamine | |
EP1944027A4 (en) | Pharmaceutical composition for treatment or prevention of nephritis and method for producing same | |
WO2006129095A3 (en) | Sustained release preparations of pro-insulin c-peptide | |
WO2006008757A3 (en) | Stabilized pharmaceutical compositions of pravastatin | |
NZ523606A (en) | Pharmaceutical compositions and methods for use | |
WO2002094178A3 (en) | Treatment of renal fibrosis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DPEN | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
122 | Ep: pct application non-entry in european phase |